 |
|
Pulmonary MycobacteriosisReport of Seven Cases
HARRY R. ELSTON, MS;
OREST J. PARRILLO, MD;
MORRIS MEIBERGER, MD;
WILLIAM P. KLEITSCH, MD
Arch Intern Med. 1964;113(3):365-372.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Although the existence of acid-fast mycobacteria other than tubercle bacilli has long been known, the clinical significance was not important in the days of nonspecific therapy for tuberculosis. However, with the development of specific antituberculosis chemotherapeutic agents and with an appreciation of the significance of drug resistance in the mycobacteria, it is increasingly apparent that unclassified organisms have gradually become important as etiologic agents of disease. As bacteriologic techniques were developed to distinguish more closely the acid-fast mycobacteria from each other and to evaluate drug resistance in the various groups, a startling fact became apparent. It was soon discovered that these unclassified acid-fast mycobacteria which in the prechemotherapy years had been classified as harmless saprophytes were in fact pathogenic. Today there is no doubt that there are acid-fast mycobacteria which can be distinguished from Mycobacterium tuberculosis by standard bacteriologic techniques and which produce a disease in the lungs and elsewhere
. . . [Full Text PDF of this Article]
Author Affiliations
OMAHA
Section of Microbiology Research (Mr. Elston); Assistant Chief, Medical Service (Dr. Parrillo); Chief, Section of Tuberculosis (Dr. Meiberger); and Chief, Surgical Service (Dr. Kleitsch).
Sections of microbiology research and tuberculosis, and the medical and surgical services, Veterans Administration Hospital.
Footnotes
Received for publication June 3, 1963; accepted Sept 18.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
